BDBM15863 1-{[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-yl]methyl}-N-[1-(propan-2-yl)piperidin-4-yl]-1H-indole-2-carboxamide::2-carboxyindole 24

SMILES CC(C)N1CCC(CC1)NC(=O)c1cc2ccccc2n1Cc1nnc(s1)-c1ccc(Cl)s1

InChI Key InChIKey=GREPHJSRGKVNIG-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 15863   

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM15863(1-{[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-y...)
Affinity DataKi:  4nM ΔG°:  -11.4kcal/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2007
Entry Details Article
PubMed